Radicava ORS
E561114
Radicava ORS is an oral formulation of the drug edaravone used to slow functional decline in adults with amyotrophic lateral sclerosis (ALS).
All labels observed (1)
| Label | Occurrences |
|---|---|
| Radicava ORS canonical | 4 |
How this entity was disambiguated
This entity first appeared as the object of triple T6005090 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Radicava ORS Context triple: [Edaravone, hasBrandName, Radicava ORS]
-
A.
Ors
Ors is a small commune in northern France, known for its World War I history and military cemetery.
-
B.
OROLSI
OROLSI is a United Nations office responsible for supporting rule of law, security sector reform, and related institution-building in conflict and post-conflict settings.
-
C.
Radicale
Radicale is a lightweight, open-source CalDAV and CardDAV server designed for simple calendar and contact synchronization.
-
D.
ORC
ORC (Optimized Row Columnar) is a highly efficient, columnar storage file format commonly used in big data systems to enable fast analytics and compression.
-
E.
ORC
ORC is the abbreviation for the Organized Reserve Corps, a former component of the United States Army Reserve structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Radicava ORS Target entity description: Radicava ORS is an oral formulation of the drug edaravone used to slow functional decline in adults with amyotrophic lateral sclerosis (ALS).
-
A.
Ors
Ors is a small commune in northern France, known for its World War I history and military cemetery.
-
B.
OROLSI
OROLSI is a United Nations office responsible for supporting rule of law, security sector reform, and related institution-building in conflict and post-conflict settings.
-
C.
Radicale
Radicale is a lightweight, open-source CalDAV and CardDAV server designed for simple calendar and contact synchronization.
-
D.
ORC
ORC (Optimized Row Columnar) is a highly efficient, columnar storage file format commonly used in big data systems to enable fast analytics and compression.
-
E.
ORC
ORC is the abbreviation for the Organized Reserve Corps, a former component of the United States Army Reserve structure.
- F. None of above. chosen
Statements (37)
| Predicate | Object |
|---|---|
| instanceOf |
oral formulation
ⓘ
pharmaceutical drug ⓘ |
| administrationSchedule | cyclic dosing regimen ⓘ |
| adverseEffect |
contusion
ⓘ
eczema ⓘ gait disturbance ⓘ headache ⓘ respiratory discomfort ⓘ |
| approvalFor | treatment of ALS ⓘ |
| benefit | oral administration alternative to IV edaravone ⓘ |
| containsChemicalSubstance | edaravone ⓘ |
| contraindication | known hypersensitivity to edaravone ⓘ |
| countryOfApproval |
United States
ⓘ
linked to:
United States of America
|
| developer | Mitsubishi Tanabe Pharma ⓘ |
| drugClass | free radical scavenger ⓘ |
| hasAbbreviation | Radicava ORS ⓘ |
| hasActiveIngredient | edaravone ⓘ |
| hasBrandName | Radicava ORS ⓘ |
| hasDosageForm | oral suspension ⓘ |
| indication |
ALS
ⓘ
amyotrophic lateral sclerosis ⓘ |
| isReformulationOf | intravenous edaravone ⓘ |
| legalStatus | prescription only ⓘ |
| marketingAuthorizationHolder |
Mitsubishi Tanabe Pharma America
ⓘ
linked to:
Mitsubishi Tanabe Pharma
|
| mechanismOfAction | acts as an antioxidant to reduce oxidative stress ⓘ |
| pharmaceuticalForm | ready-to-drink oral solution ⓘ |
| pharmacologicalEffect | slows loss of physical function in ALS patients ⓘ |
| regulatoryAgencyApproval |
U.S. Food and Drug Administration
ⓘ
linked to:
Food and Drug Administration
|
| relatedIntravenousFormulation | Radicava ⓘ |
| requiresMonitoring | hypersensitivity symptoms ⓘ |
| routeOfAdministration | oral ⓘ |
| storageCondition | store at controlled room temperature ⓘ |
| targetPopulation | adults ⓘ |
| therapeuticArea | neurology ⓘ |
| therapeuticUse | to slow functional decline in adults with ALS ⓘ |
| treatsDisease | motor neuron disease ALS ⓘ |
| warning | may cause hypersensitivity reactions ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Radicava ORS Description of subject: Radicava ORS is an oral formulation of the drug edaravone used to slow functional decline in adults with amyotrophic lateral sclerosis (ALS).
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.